Peanut Allergy Market Expands with Rising Food Allergy Prevalence, Immunotherapy Innovation, and Advanced Allergy Management Solutions

The Global Peanut Allergy Market is witnessing substantial growth as rising prevalence of food allergies, increasing awareness of anaphylaxis risks, advancements in immunotherapy, and expanding healthcare investments drive market expansion worldwide. According to market estimates, the global peanut allergy market was valued at approximately USD 1.9 billion in 2025 and is projected to reach nearly USD 4.3 billion by 2032, growing at a CAGR of around 12.1% during the forecast period. This robust growth is fueled by increasing diagnosis rates, growing pediatric allergy cases, rising consumer demand for preventive healthcare, advancements in oral immunotherapy (OIT), biologics, and epinephrine delivery systems. Major growth drivers include expanding awareness campaigns, improved diagnostic technologies, regulatory approvals for allergy therapeutics, school safety mandates, and broader access to emergency treatment solutions. Significant opportunities are emerging through biologic therapies, personalized immunotherapy, wearable allergy monitoring devices, digital health platforms, and next-generation desensitization technologies.

Evaluate the Report Before Purchase – Get a Free Sample Today https://www.maximizemarketresearch.com/request-sample/199509/ 

US Market Trends and Investments 
In 2025, the United States remains the dominant peanut allergy market due to high food allergy prevalence, advanced healthcare infrastructure, strong pharmaceutical innovation, and regulatory support for allergy therapeutics. Major companies such as Stallergenes Greer, DBV Technologies, Kaléo, Aquestive Therapeutics, and Sanofi are significantly increasing investments in oral immunotherapy, epicutaneous immunotherapy patches, biologic drug development, improved epinephrine auto-injectors, and digital allergy management platforms. Key U.S. trends include expanding FDA approvals for innovative immunotherapies, rising school and workplace allergy safety policies, broader pediatric treatment adoption, increased telehealth integration for allergy management, and growing private investment in biotechnology-based allergy solutions. Public health initiatives and pharmaceutical R&D continue to strengthen market growth.

Peanut Allergy Market Segmentation 
Based on treatment type, epinephrine auto-injectors hold the largest market share due to widespread emergency use and regulatory requirements for anaphylaxis management. By therapy type, oral immunotherapy is rapidly expanding and dominates long-term treatment strategies due to increasing clinical adoption. In terms of end-user, hospitals and specialty allergy clinics command the highest market share due to advanced diagnosis, treatment monitoring, and emergency care capabilities.

Evaluate the Report Before Purchase – Get a Free Sample Today https://www.maximizemarketresearch.com/request-sample/199509/ 

Peanut Allergy Key Players include:
1. DBV Technologies
2. Sanofi
3. Vedanta Biosciences Inc
4. Alladapt Immunotherapeutics, Inc.
5. InnoUp
6. Cambridge Allergy Ltd.
7. COUR Pharmaceuticals
8. Regeneron Pharmaceuticals Inc.
9. Aimmune Therapeutics
10. Moonlight Therapeutics
11. Prota Therapeutics
12. Intrommune Therapeutics
13. Blue Willow Biologics
14. Aravax Pty Ltd.

Competitive Analysis
The global peanut allergy market is highly competitive, with major companies focusing on immunotherapy innovation, biologics, and patient safety technologies:

• Stallergenes Greer leads through allergy immunotherapy expertise, diagnostics, and personalized treatment platforms.

• DBV Technologies strengthens market share through epicutaneous immunotherapy innovation and pediatric allergy solutions.

• Kaléo, Inc. drives growth through advanced epinephrine auto-injector technologies and emergency allergy response systems.

• Aquestive Therapeutics supports expansion through oral film delivery innovations and allergy treatment technologies.

• Sanofi S.A. expands through biologic therapies, immunology research, and broader allergy treatment investments.

These companies are aggressively investing in desensitization therapies, biologics, wearable technologies, digital patient support, and advanced emergency treatment systems.

Regional Analysis

• United States: Largest market share driven by high allergy prevalence, advanced therapeutics, and strong healthcare spending.

• United Kingdom: National allergy awareness programs and healthcare infrastructure support market growth.

• Germany: Advanced allergy diagnostics, pharmaceutical innovation, and healthcare investments fuel expansion.

• France: Public healthcare policies and biotechnology innovation strengthen market opportunities.

• Japan: Increasing allergy awareness and advanced healthcare systems support moderate growth.

• China: Rising food allergy diagnosis rates, healthcare modernization, and biotechnology investments create emerging opportunities.

North America leads through therapeutic innovation and awareness, while Europe maintains strong growth through healthcare policy support and biotechnology advancements.

Conclusion
The Global Peanut Allergy Market is positioned for sustained long-term growth, fueled by rising allergy prevalence, immunotherapy innovation, improved diagnostics, and expanding healthcare awareness. Major opportunities lie in biologic therapies, personalized immunotherapy, wearable monitoring, pediatric treatment expansion, and digital allergy management ecosystems. As healthcare systems increasingly prioritize prevention, early diagnosis, and long-term disease management, peanut allergy solutions will remain critical within the global allergy therapeutics sector. Companies investing in next-generation immunotherapies, emergency care technologies, and patient-centered innovation are expected to secure substantial competitive advantages in this rapidly evolving healthcare market.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com